SEC restatements
Travere Therapeutics, Inc. (TVTX)
Travere Therapeutics, Inc. has 30 revised figures in later SEC filings: annual figures whose value in a later filing differs from the value on record first. Each revision below links to both filings.
CIK 0001438533
Most recent revisions
Newest 3 of 30 · as filed · by the latest filing stating each revision
| Figure | On record first | Revised |
|---|---|---|
| InventoryPeriod ended Dec 31, 2024 | $6.20MFiled Feb 21, 2025 (opens EDGAR in a new tab) | $41.86MFiled Feb 19, 2026 (opens EDGAR in a new tab) |
| Amortization of intangiblesPeriod ended Dec 31, 2022 | $30.96MFiled Feb 23, 2023 (opens EDGAR in a new tab) | $18.60MFiled Feb 21, 2025 (opens EDGAR in a new tab) |
| Cost of revenuePeriod ended Dec 31, 2022 | $7.59MFiled Feb 23, 2023 (opens EDGAR in a new tab) | $4.42MFiled Feb 21, 2025 (opens EDGAR in a new tab) |
A revised figure is not by itself a correction of an error. Companies re-present prior figures for ordinary reasons too, such as a discontinued business, a merger or a new accounting standard. The value on record first is the earliest filing we hold that states the figure; the revised value is the latest revised value on record, linked to the latest filing that states it.
revised annual figures for Travere Therapeutics, Inc.
This page shows the most recent 3. The complete list, every revised figure with both values and both filings, is in the API and the MCP server (get_revisions) on the Analyst plan.
Programmatic access
Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.
- Every revised figure for this company, with both values and both filings (Analyst)
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/revisions/TVTX
MCP tool:
get_revisions ticker=TVTX
Not investment advice. Figures are shown as filed with the SEC; each one links to the filing it came from.